5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study.

about

5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study.

Item

http://www.wikidata.org/entity/Q47101230

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

5D proteomic approach for the ...... oid leukaemia as a case study.

@en

5D proteomic approach for the ...... oid leukaemia as a case study.

@nl

type

Item

label

5D proteomic approach for the ...... oid leukaemia as a case study.

@en

5D proteomic approach for the ...... oid leukaemia as a case study.

@nl

prefLabel

5D proteomic approach for the ...... oid leukaemia as a case study.

@en

5D proteomic approach for the ...... oid leukaemia as a case study.

@nl

P1476

5D proteomic approach for the ...... oid leukaemia as a case study.

@en

P2093

Atta-Ur-Rahman

http://www.w3.org/2001/XMLSchema#string

Mahwish Saleem

http://www.w3.org/2001/XMLSchema#string

Syed Ghulam Musharraf

http://www.w3.org/2001/XMLSchema#string

Syed Kashif Raza

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

An investigation into the human serum "interactome"

STRING 8--a global view on proteins and their functional interactions in 630 organisms

Survey of activated FLT3 signaling in leukemia

The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia.

Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.

Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.

Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.

P2888

s41598-017-16699-2

P304

16440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-16699-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tahir Shamsi

M. Iqbal Choudhary

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092869972

http://www.w3.org/2001/XMLSchema#string

P698

29180721

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5703949

http://www.w3.org/2001/XMLSchema#string